|

1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors

RECRUITINGPhase 3Sponsored by dmitry enikeev
Actively Recruiting
PhasePhase 3
Sponsordmitry enikeev
Started2026-06-08
Est. completion2027-06-08
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

to compare pathological and oncological outcomes of TURBT versus ERBT in patients with bladder tumors sizes \>2.5cm.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients aged ≥18 years with
* Bladder tumor \>2.5cm measured on US\\CT\\MRI (suspected non-muscle invasive bladder cancer).
* Performance status (ECOG) ≤2.
* Signed informed consent form to participate in the study

Exclusion Criteria:

* Multifocal tumors (≥4 lesions).
* Prior history of BCG unresponsive bladder cancer.
* Prior systemic chemotherapy or immunotherapy for any malignancy.
* UTUC.
* Evidence of metastatic disease.
* Contraindications for endoscopic surgery for bladder tumor.
* Benign bladder tumor on postoperative pathology.

Conditions3

CancerNMIBCTCC

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.